When normalized to β-actin, Western blot analysis performed on tissue lysates demonstrated a significant increase in CDO1 expression in grade 4 glioma (Fig. 1C; Western blots provided in Supplementary Fig. S2). This evidence concerns the gene ACTB and central nervous system cancer.